GLP-1 agonists carry a rodent-based thyroid tumor warning, but human data over 7+ years has not confirmed this risk
DSIP should not be presented as an approved UK treatment for insomnia, narcolepsy, pain, anxiety, stress, alcohol withdrawal, opioid withdrawal or another medical condition
Medically reviewed by Oghenefejiro Okifo | MD , Harvard Medical School | Henry Ford Hospital - Detroit, MI on October 29th, 2025
Interestingly, the elimination half-life of BPC-157 is relatively short at less than 30 minutes, with intact peptide becoming undetectable after approximately four hours
We've seen it time and again in the literature
Bill R13.0 when the note only says "difficulty," and you've claimed more severity than the record supports